Close
Close

Anti-IGHG1 Protein A Scaffold (CAT#: AFB-09LY)

Datasheet
DESCRIPTION CATALOG # SIZE PRICE
Anti-Human IgG Protein A scaffold AFB-09LY 1mg Please Inquiry

PRODUCT INFORMATION

  • Product Overview
  • This Anti-IgG Protein A Scaffold Molecule is modified with a unique C-terminal cysteine for directed single-point chemical modification, facilitating labelling with fluorescent dyes, biotin or coupling to matrices. However, tail-to-tail dimers are spontaneously generated via a disulphide bridge between the C-terminal cysteines. Prior to coupling via the C-terminal the Protein A Scaffold Molecule needs to be reduced to expose the reactive cysteine residue. Recommended reducing condition is 20mM DTT at a pH above 7.5 and incubation at room temperature for 2 hours. Remove excess DTT by passage through a desalting column, not by dialysis.
  • Species Reactivity
  • Human
  • Expression Host
  • E. coli
  • Specific Activity
  • This product recognises the Fc part of IgG from several species with similar binding preferences as Protein A in terms of subclass specificities. This molecule binds with high affinity to human IgG of IgG1, IgG2 and IgG4 subclasses which comprise 92-98% o
  • Storage
  • Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

BACKGROUND

  • Function
  • Antigen binding; protein binding.
  • Synonyms
  • immunoglobulin heavy constant gamma 1 (G1m marker); IGHG1; Ig gamma 1 chain C region; Immunoglobin heavy constant gamma 1; Immunoglobulin G; IgG

Customer reviews and Q&As    

Online Inquiry
CONTACT US
USA:
Europe:
Germany:
Call us at:
USA:
UK:
Germany:
Fax:
Email:
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us
© 2024 Creative Biolabs. | Contact Us